25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GENNEX LABORATORIES LTD.
Buy, Hold or Sell?

Let's analyze GENNEX LABORATORIES LTD. together

I guess you are interested in GENNEX LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GENNEX LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about GENNEX LABORATORIES LTD.

I send you an email if I find something interesting about GENNEX LABORATORIES LTD..

1. Quick Overview

1.1. Quick analysis of GENNEX LABORATORIES LTD. (30 sec.)










1.2. What can you expect buying and holding a share of GENNEX LABORATORIES LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR7.76
Expected worth in 1 year
INR20.60
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR12.84
Return On Investment
66.8%

For what price can you sell your share?

Current Price per Share
INR19.21
Expected price per share
INR15.77 - INR22.50
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of GENNEX LABORATORIES LTD. (5 min.)




Live pricePrice per Share (EOD)
INR19.21
Intrinsic Value Per Share
INR-30.08 - INR-23.73
Total Value Per Share
INR-22.32 - INR-15.97

2.2. Growth of GENNEX LABORATORIES LTD. (5 min.)




Is GENNEX LABORATORIES LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$20.8m$9.4m$11.3m54.5%

How much money is GENNEX LABORATORIES LTD. making?

Current yearPrevious yearGrowGrow %
Making money$1.5m$580.6k$973.9k62.7%
Net Profit Margin15.2%7.5%--

How much money comes from the company's main activities?

2.3. Financial Health of GENNEX LABORATORIES LTD. (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of GENNEX LABORATORIES LTD.?

Welcome investor! GENNEX LABORATORIES LTD.'s management wants to use your money to grow the business. In return you get a share of GENNEX LABORATORIES LTD..

First you should know what it really means to hold a share of GENNEX LABORATORIES LTD.. And how you can make/lose money.

Speculation

The Price per Share of GENNEX LABORATORIES LTD. is INR19.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of GENNEX LABORATORIES LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in GENNEX LABORATORIES LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR7.76. Based on the TTM, the Book Value Change Per Share is INR3.21 per quarter. Based on the YOY, the Book Value Change Per Share is INR1.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of GENNEX LABORATORIES LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.010.0%0.010.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.040.2%0.040.2%0.010.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.040.2%0.040.2%0.010.1%0.010.1%0.010.1%
Usd Price Per Share0.20-0.20-0.08-0.10-0.08-
Price to Earnings Ratio29.02-29.02-22.94-24.67-33.41-
Price-to-Total Gains Ratio5.24-5.24-5.14-16.02-24.86-
Price to Book Ratio2.17-2.17-1.40-1.89-2.00-
Price-to-Total Gains Ratio5.24-5.24-5.14-16.02-24.86-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.226678
Number of shares4411
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.040.01
Usd Total Gains Per Share0.040.01
Gains per Quarter (4411 shares)167.0754.22
Gains per Year (4411 shares)668.27216.87
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106686580217207
20133713260434424
30200519940651641
40267326620867858
5033413330010841075
6040103998013011292
7046784666015181509
8053465334017351726
9060146002019521943
10066836670021692160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of GENNEX LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.2103.2100%1.244+158%1.042+208%0.970+231%
Book Value Per Share--7.7587.7580%4.549+71%4.259+82%3.572+117%
Current Ratio--4.0154.0150%1.650+143%2.254+78%2.006+100%
Debt To Asset Ratio--0.2330.2330%0.393-41%0.336-31%0.346-33%
Debt To Equity Ratio--0.3140.3140%0.647-51%0.519-39%0.538-42%
Dividend Per Share----0%-0%-0%-0%
Eps--0.5790.5790%0.279+108%0.320+81%0.254+128%
Free Cash Flow Per Share---2.053-2.0530%-0.944-54%-0.558-73%-0.329-84%
Free Cash Flow To Equity Per Share---2.053-2.0530%0.247-932%-0.328-84%-0.185-91%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---23.728--------
Intrinsic Value_10Y_min---30.077--------
Intrinsic Value_1Y_max---0.952--------
Intrinsic Value_1Y_min---1.404--------
Intrinsic Value_3Y_max---3.947--------
Intrinsic Value_3Y_min---5.637--------
Intrinsic Value_5Y_max---8.252--------
Intrinsic Value_5Y_min---11.394--------
Market Cap--3823395399.9403823395399.9400%1128750559.200+239%1477070789.088+159%1183562923.843+223%
Net Profit Margin--0.1520.1520%0.075+103%0.078+94%0.064+136%
Operating Margin----0%-0%0.010-100%0.032-100%
Operating Ratio--1.3941.3940%1.551-10%1.510-8%1.282+9%
Pb Ratio2.476+12%2.1672.1670%1.405+54%1.890+15%1.998+8%
Pe Ratio33.163+12%29.02029.0200%22.938+27%24.670+18%33.408-13%
Price Per Share19.210+12%16.81016.8100%6.390+163%8.310+102%7.158+135%
Price To Free Cash Flow Ratio-9.359-14%-8.190-8.1900%-6.770-17%-10.027+22%-3.945-52%
Price To Total Gains Ratio5.985+12%5.2375.2370%5.135+2%16.021-67%24.860-79%
Quick Ratio--3.3153.3150%1.323+151%2.072+60%1.646+101%
Return On Assets--0.0570.0570%0.037+54%0.051+13%0.046+25%
Return On Equity--0.0770.0770%0.061+26%0.076+1%0.070+10%
Total Gains Per Share--3.2103.2100%1.244+158%1.042+208%0.970+231%
Usd Book Value--20822822.80020822822.8000%9481286.312+120%8873858.231+135%6969823.828+199%
Usd Book Value Change Per Share--0.0380.0380%0.015+158%0.012+208%0.011+231%
Usd Book Value Per Share--0.0920.0920%0.054+71%0.050+82%0.042+117%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0070.0070%0.003+108%0.004+81%0.003+128%
Usd Free Cash Flow---5508995.200-5508995.2000%-1967390.400-64%-1430028.034-74%-862487.196-84%
Usd Free Cash Flow Per Share---0.024-0.0240%-0.011-54%-0.007-73%-0.004-84%
Usd Free Cash Flow To Equity Per Share---0.024-0.0240%0.003-932%-0.004-84%-0.002-91%
Usd Market Cap--45116065.71945116065.7190%13319256.599+239%17429435.311+159%13966042.501+223%
Usd Price Per Share0.227+12%0.1980.1980%0.075+163%0.098+102%0.084+135%
Usd Profit--1554650.0001554650.0000%580651.686+168%658758.458+136%496696.500+213%
Usd Revenue--10232299.20010232299.2000%7741148.690+32%7759619.372+32%6936720.211+48%
Usd Total Gains Per Share--0.0380.0380%0.015+158%0.012+208%0.011+231%
 EOD+3 -3MRQTTM+0 -0YOY+24 -85Y+22 -1110Y+23 -10

3.3 Fundamental Score

Let's check the fundamental score of GENNEX LABORATORIES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1533.163
Price to Book Ratio (EOD)Between0-12.476
Net Profit Margin (MRQ)Greater than00.152
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.315
Current Ratio (MRQ)Greater than14.015
Debt to Asset Ratio (MRQ)Less than10.233
Debt to Equity Ratio (MRQ)Less than10.314
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.057
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of GENNEX LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.373
Ma 20Greater thanMa 5020.185
Ma 50Greater thanMa 10022.103
Ma 100Greater thanMa 20018.946
OpenGreater thanClose19.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About GENNEX LABORATORIES LTD.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit GENNEX LABORATORIES LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • A Net Profit Margin of 15.2% means that ₹0.15 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 15.2%. The company is making a huge profit. +2
  • The TTM is 15.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.2%TTM15.2%0.0%
TTM15.2%YOY7.5%+7.7%
TTM15.2%5Y7.8%+7.4%
5Y7.8%10Y6.4%+1.4%
4.3.1.2. Return on Assets

Shows how efficient GENNEX LABORATORIES LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • 5.7% Return on Assets means that GENNEX LABORATORIES LTD. generated ₹0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 5.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.7%TTM5.7%0.0%
TTM5.7%YOY3.7%+2.0%
TTM5.7%5Y5.1%+0.7%
5Y5.1%10Y4.6%+0.5%
4.3.1.3. Return on Equity

Shows how efficient GENNEX LABORATORIES LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • 7.7% Return on Equity means GENNEX LABORATORIES LTD. generated ₹0.08 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY6.1%+1.6%
TTM7.7%5Y7.6%+0.1%
5Y7.6%10Y7.0%+0.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of GENNEX LABORATORIES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient GENNEX LABORATORIES LTD. is operating .

  • Measures how much profit GENNEX LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y1.0%-1.0%
5Y1.0%10Y3.2%-2.2%
4.3.2.2. Operating Ratio

Measures how efficient GENNEX LABORATORIES LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.39 means that the operating costs are ₹1.39 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 1.394. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.394. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.394TTM1.3940.000
TTM1.394YOY1.551-0.157
TTM1.3945Y1.510-0.115
5Y1.51010Y1.282+0.228
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of GENNEX LABORATORIES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if GENNEX LABORATORIES LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 4.01 means the company has ₹4.01 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 4.015. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.015. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.015TTM4.0150.000
TTM4.015YOY1.650+2.365
TTM4.0155Y2.254+1.761
5Y2.25410Y2.006+0.248
4.4.3.2. Quick Ratio

Measures if GENNEX LABORATORIES LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • A Quick Ratio of 3.31 means the company can pay off ₹3.31 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 3.315. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.315. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.315TTM3.3150.000
TTM3.315YOY1.323+1.992
TTM3.3155Y2.072+1.242
5Y2.07210Y1.646+0.426
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of GENNEX LABORATORIES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of GENNEX LABORATORIES LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare GENNEX LABORATORIES LTD. to industry mean.
  • A Debt to Asset Ratio of 0.23 means that GENNEX LABORATORIES LTD. assets are financed with 23.3% credit (debt) and the remaining percentage (100% - 23.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 0.233. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.233. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.233TTM0.2330.000
TTM0.233YOY0.393-0.160
TTM0.2335Y0.336-0.103
5Y0.33610Y0.346-0.010
4.5.4.2. Debt to Equity Ratio

Measures if GENNEX LABORATORIES LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • A Debt to Equity ratio of 31.4% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GENNEX LABORATORIES LTD.:

  • The MRQ is 0.314. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.314. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.314TTM0.3140.000
TTM0.314YOY0.647-0.333
TTM0.3145Y0.519-0.204
5Y0.51910Y0.538-0.019
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings GENNEX LABORATORIES LTD. generates.

  • Above 15 is considered overpriced but always compare GENNEX LABORATORIES LTD. to the  industry mean.
  • A PE ratio of 29.02 means the investor is paying ₹29.02 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GENNEX LABORATORIES LTD.:

  • The EOD is 33.163. Based on the earnings, the company is overpriced. -1
  • The MRQ is 29.020. Based on the earnings, the company is overpriced. -1
  • The TTM is 29.020. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD33.163MRQ29.020+4.143
MRQ29.020TTM29.0200.000
TTM29.020YOY22.938+6.082
TTM29.0205Y24.670+4.350
5Y24.67010Y33.408-8.738
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GENNEX LABORATORIES LTD.:

  • The EOD is -9.359. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8.190. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.190. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.359MRQ-8.190-1.169
MRQ-8.190TTM-8.1900.000
TTM-8.190YOY-6.770-1.420
TTM-8.1905Y-10.027+1.837
5Y-10.02710Y-3.945-6.082
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of GENNEX LABORATORIES LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 2.17 means the investor is paying ₹2.17 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of GENNEX LABORATORIES LTD.:

  • The EOD is 2.476. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.167. Based on the equity, the company is underpriced. +1
  • The TTM is 2.167. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.476MRQ2.167+0.309
MRQ2.167TTM2.1670.000
TTM2.167YOY1.405+0.762
TTM2.1675Y1.890+0.276
5Y1.89010Y1.998-0.107
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,299,858
Total Liabilities535,212
Total Stockholder Equity1,703,815
 As reported
Total Liabilities 535,212
Total Stockholder Equity+ 1,703,815
Total Assets = 2,299,858

Assets

Total Assets2,299,858
Total Current Assets1,618,141
Long-term Assets681,716
Total Current Assets
Cash And Cash Equivalents 4,786
Short-term Investments 1,157,902
Net Receivables 178,112
Inventory 251,750
Other Current Assets 25,591
Total Current Assets  (as reported)1,618,141
Total Current Assets  (calculated)1,618,141
+/-0
Long-term Assets
Property Plant Equipment 550,241
Intangible Assets 29,406
Long-term Assets Other 99,663
Long-term Assets  (as reported)681,716
Long-term Assets  (calculated)679,310
+/- 2,406

Liabilities & Shareholders' Equity

Total Current Liabilities403,048
Long-term Liabilities132,164
Total Stockholder Equity1,703,815
Total Current Liabilities
Short Long Term Debt 57,205
Accounts payable 151,803
Total Current Liabilities  (as reported)403,048
Total Current Liabilities  (calculated)209,008
+/- 194,040
Long-term Liabilities
Long-term Liabilities  (as reported)132,164
Long-term Liabilities  (calculated)0
+/- 132,164
Total Stockholder Equity
Total Stockholder Equity (as reported)1,703,815
Total Stockholder Equity (calculated)0
+/- 1,703,815
Other
Capital Stock227,448
Common Stock Shares Outstanding 227,448
Net Debt 52,419
Net Invested Capital 1,761,020
Net Working Capital 1,215,093
Property Plant and Equipment Gross 550,241



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
492,111
504,660
517,306
569,437
589,019
680,265
1,323,163
2,299,858
2,299,8581,323,163680,265589,019569,437517,306504,660492,111
   > Total Current Assets 
262,430
276,620
290,446
349,682
376,690
471,817
486,827
1,618,141
1,618,141486,827471,817376,690349,682290,446276,620262,430
       Cash And Cash Equivalents 
37
565
1,951
1,937
8,830
79,918
145,013
4,786
4,786145,01379,9188,8301,9371,95156537
       Short-term Investments 
0
0
0
0
214,680
189,115
72,793
1,157,902
1,157,90272,793189,115214,6800000
       Net Receivables 
130,557
157,832
151,304
109,736
89,465
113,135
94,166
178,112
178,11294,166113,13589,465109,736151,304157,832130,557
       Inventory 
28,904
23,386
53,271
74,373
50,185
77,367
156,925
251,750
251,750156,92577,36750,18574,37353,27123,38628,904
       Other Current Assets 
100,086
93,623
82,002
162,052
11,669
9,071
12,302
25,591
25,59112,3029,07111,669162,05282,00293,623100,086
   > Long-term Assets 
0
0
226,880
219,755
212,329
208,448
836,336
681,716
681,716836,336208,448212,329219,755226,88000
       Property Plant Equipment 
157,411
155,813
156,381
149,277
141,257
136,982
676,460
550,241
550,241676,460136,982141,257149,277156,381155,813157,411
       Intangible Assets 
0
0
0
0
0
0
61,084
29,406
29,40661,084000000
       Long-term Assets Other 
0
0
0
0
2,797
0
97,319
99,663
99,66397,31902,7970000
> Total Liabilities 
182,743
186,985
179,153
212,721
191,922
242,114
519,664
535,212
535,212519,664242,114191,922212,721179,153186,985182,743
   > Total Current Liabilities 
171,399
176,620
173,003
208,577
190,392
242,081
295,130
403,048
403,048295,130242,081190,392208,577173,003176,620171,399
       Short-term Debt 
37,516
21,216
45,387
49,843
73,619
101,237
10,536
0
010,536101,23773,61949,84345,38721,21637,516
       Short Long Term Debt 
0
0
4,670
49,843
73,619
101,237
10,536
57,205
57,20510,536101,23773,61949,8434,67000
       Accounts payable 
94,572
121,644
81,544
81,320
59,447
77,405
244,682
151,803
151,803244,68277,40559,44781,32081,544121,64494,572
       Other Current Liabilities 
37,708
32,457
44,083
74,206
29,172
0
0
0
00029,17274,20644,08332,45737,708
   > Long-term Liabilities 
0
0
46,867
4,144
1,530
32
162,881
132,164
132,164162,881321,5304,14446,86700
       Long term Debt Total 
855
3,486
0
0
0
0
162,881
0
0162,88100003,486855
       Long-term Liabilities Other 
0
0
40,717
0
1
-1
0
0
00-11040,71700
> Total Stockholder Equity
309,368
317,675
338,152
356,716
397,097
438,152
803,499
1,703,815
1,703,815803,499438,152397,097356,716338,152317,675309,368
   Common Stock
126,503
126,503
126,503
126,503
126,503
126,503
180,193
0
0180,193126,503126,503126,503126,503126,503126,503
   Retained Earnings 
113,615
121,922
142,399
160,963
270,594
311,649
623,306
0
0623,306311,649270,594160,963142,399121,922113,615
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
9,250
9,250
9,250
9,250
0
0
0
0
00009,2509,2509,2509,250



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue867,144
Cost of Revenue-488,522
Gross Profit378,622378,622
 
Operating Income (+$)
Gross Profit378,622
Operating Expense-720,526
Operating Income146,618-341,904
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense720,5260
 
Net Interest Income (+$)
Interest Income0
Interest Expense-30,760
Other Finance Cost-0
Net Interest Income-30,760
 
Pretax Income (+$)
Operating Income146,618
Net Interest Income-30,760
Other Non-Operating Income Expenses0
Income Before Tax (EBT)164,918146,618
EBIT - interestExpense = -30,760
131,750
162,510
Interest Expense30,760
Earnings Before Interest and Taxes (EBIT)0195,678
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax164,918
Tax Provision-33,168
Net Income From Continuing Ops131,750131,750
Net Income131,750
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net030,760
 

Technical Analysis of GENNEX LABORATORIES LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of GENNEX LABORATORIES LTD.. The general trend of GENNEX LABORATORIES LTD. is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine GENNEX LABORATORIES LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GENNEX LABORATORIES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 19.66 < 19.70 < 22.50.

The bearish price targets are: 17.40 > 17.33 > 15.77.

Tweet this
GENNEX LABORATORIES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GENNEX LABORATORIES LTD.. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GENNEX LABORATORIES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GENNEX LABORATORIES LTD.. The current macd is -0.67503138.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the GENNEX LABORATORIES LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for GENNEX LABORATORIES LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the GENNEX LABORATORIES LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
GENNEX LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartGENNEX LABORATORIES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GENNEX LABORATORIES LTD.. The current adx is 16.74.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell GENNEX LABORATORIES LTD. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
GENNEX LABORATORIES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GENNEX LABORATORIES LTD.. The current sar is 21.84.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
GENNEX LABORATORIES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GENNEX LABORATORIES LTD.. The current rsi is 40.37. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
GENNEX LABORATORIES LTD. Daily Relative Strength Index (RSI) ChartGENNEX LABORATORIES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GENNEX LABORATORIES LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the GENNEX LABORATORIES LTD. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
GENNEX LABORATORIES LTD. Daily Stochastic Oscillator ChartGENNEX LABORATORIES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GENNEX LABORATORIES LTD.. The current cci is -108.96863512.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
GENNEX LABORATORIES LTD. Daily Commodity Channel Index (CCI) ChartGENNEX LABORATORIES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GENNEX LABORATORIES LTD.. The current cmo is -24.83669038.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
GENNEX LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) ChartGENNEX LABORATORIES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GENNEX LABORATORIES LTD.. The current willr is -82.45614035.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
GENNEX LABORATORIES LTD. Daily Williams %R ChartGENNEX LABORATORIES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GENNEX LABORATORIES LTD..

GENNEX LABORATORIES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GENNEX LABORATORIES LTD.. The current atr is 1.15728684.

GENNEX LABORATORIES LTD. Daily Average True Range (ATR) ChartGENNEX LABORATORIES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GENNEX LABORATORIES LTD.. The current obv is 180,785,466.

GENNEX LABORATORIES LTD. Daily On-Balance Volume (OBV) ChartGENNEX LABORATORIES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GENNEX LABORATORIES LTD.. The current mfi is 30.69.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
GENNEX LABORATORIES LTD. Daily Money Flow Index (MFI) ChartGENNEX LABORATORIES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GENNEX LABORATORIES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-09MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-13ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

GENNEX LABORATORIES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GENNEX LABORATORIES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.373
Ma 20Greater thanMa 5020.185
Ma 50Greater thanMa 10022.103
Ma 100Greater thanMa 20018.946
OpenGreater thanClose19.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of GENNEX LABORATORIES LTD. with someone you think should read this too:
  • Are you bullish or bearish on GENNEX LABORATORIES LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about GENNEX LABORATORIES LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GENNEX LABORATORIES LTD.

I send you an email if I find something interesting about GENNEX LABORATORIES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about GENNEX LABORATORIES LTD..

Receive notifications about GENNEX LABORATORIES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.